Advertisement
The rebalanced Indexes, including the rebalanced Index Shares, are basedon the closing prices as of March 14, 2008.
In accordance with the Exemptive Order, a complete list of theconstituents reflecting the rebalancing will be posted atwww.healthsharesinc.com/content/view/53/274/.
Advertisement
About QED International Associates
QED International, based in New York, is a leading financial industryconsulting firm specializing in quantitative modeling and the design,development and maintenance of indexes and Exchange Traded Funds. For moreinformation, visit the company's website at www.qedinternational.comAutoimmune-Inflammation Index (HHA) Drop GW Pharmaceuticals, Inc (LSE: GWP.L) Human Genome Sciences (Nasdaq: HGSI) Ligand Pharmaceuticals, Inc. (Nasdaq: LGND) Add Fornix Biosciences N.V. (Amsterdam: FORBI.AS) Meda AB (SHSE1: MEDA A) Mitsubishi Tanabe Pharma Corporation (TSE: 4508) Cancer Index (HHK) Drop Shire PLC (Nasdaq: SHPGY) Add Ark Therapeutics Group Plc (LSE: AKT.L) Cardio Devices Index (HHE) Drop Biosphere Medical, Inc. (Nasdaq: BSMD) Add Zoll Medical Corp. (Nasdaq: ZOLL) Cardiology Index (HRD) Drop Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY) Human Genome Sciences, Inc (Nasdaq: HGSI) Vical, Inc. (Nasdaq: VICL) Add Mitsubishi Tanabe Pharma Corporation (TSE: 4508) Sangamo BioSciences Inc. (Nasdaq: SGMO) Sciele Pharma, Inc. (Nasdaq: SCRX) Composite Index (HHQ) Drop Advanced Medical Optics, Inc. (NYSE: EYE) Align Technology Inc. (Nasdaq: ALGN) Array Biopharma Inc. (Nasdaq: ARRY) ArthroCare Corp. (Nasdaq: ARTC) Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP) Fresenius Medical Care AG (XETRA: FME.DE) GEDEON RICHTER RT (XETRA: R1G1.DE) GENMAB A/S (Copenhagen: GEN.CO) H LUNDBECK A/S (Copenhagen: LUN.CO) Human Genome Sciences (Nasdaq: HGSI) Imclone Systems (Nasdaq: IMCL) Inverness Medical Innovations (Amex: IMA) Invitrogen Corp. (Nasdaq: IVGN) Medarex Inc. (Nasdaq: MEDX) Medicis Pharmaceutical (NYSE: MRX) Mentor Corp. (NYSE: MNT) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX) PDL BioPharma, Inc. (Nasdaq: PDLI) Pharmion Corp. (Nasdaq: PHRM) Progenics Pharmaceuticals Inc. (Nasdaq: PGNX) Regeneron Pharmaceuticals (Nasdaq: REGN) Respironics Inc. (Nasdaq: RESP) Sepracor Inc. (Nasdaq: SEPR) Theravance Inc. (Nasdaq: THRX) United Therapeutics Corp. (Nasdaq: UTHR) Valeant Pharmaceuticals Int'l (NYSE: VRX) Vertex Pharmaceuticals (Nasdaq: VRTX) Add Adolor Corp. (Nasdaq: ADLR) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) Alpharma Inc. (NYSE: ALO) Altus Pharmaceuticals Inc. (Nasdaq: ALTU) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI) Ark Therapeutics (LSE: AKT.L) Bavarian Nordic A/S (Copenhagen: BAVA.CO) Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD) Cardiome Pharma Corp. (Nasdaq: CRME) Coventry Health Care Inc. (NYSE: CVH) CRUCELL-ADR (Nasdaq: CRXL) CUBIST PHARMACEUTICALS INC. (Nasdaq: CBST) Discovery Laboratories Inc. (Nasdaq: DSCO) Eisai Co. Ltd. (TSE: 4523.T) Encysive Pharmaceuticals Inc. (Nasdaq: ENCY) Enzo Biochem Inc. (NYSE: ENZ) ENZON PHARMACEUTICALS INC. (Nasdaq: ENZN) Exelixis Inc. (Nasdaq: EXEL) Flamel Technologies (Nasdaq: FLML) Illumina Inc. (Nasdaq: ILMN) Incyte Corporation (Nasdaq: INCY) Integra LifeSciences Holdings (Nasdaq: IART)
